According to FutureWise analysis the market for Anticonvulsants in 2023 is US$ 25.17 billion, and is expected to reach US$ 30.96 billion by 2031 at a CAGR of 2.60%.
Anticonvulsants, often referred to as antiseizure drugs or antiepileptic medications, are primarily used to manage and prevent seizures, which can occur as part of various neurological conditions. These medications aim to alleviate the symptoms associated with seizures but do not alter the underlying duration of epilepsy itself. Epilepsy is characterized by a range of interconnected disorders affecting the brain's electrical systems, leading to recurrent seizures. These seizures can result in changes to movement, sensation, behavior, or consciousness, and typically last from a few seconds to several minutes.
Both children and adults can experience seizures, and in addition to their primary use for seizure management, anticonvulsants have been found effective in treating neuropathic pain associated with damaged or overly sensitized nerves, as seen in conditions such as fibromyalgia. Additionally, these medications can be beneficial in the treatment of bipolar disorder.
Anticonvulsants encompass a broad category of drugs, including various subtypes such as barbiturates, hydantoins, and benzodiazepines. Barbiturates, for example, are a class of sedative-hypnotic agents that not only help manage seizure disorders but also serve as anesthetics during surgical procedures and as anxiolytics to alleviate anxiety and insomnia. They enhance the effect of gamma-aminobutyric acid (GABA), an essential inhibitory neurotransmitter in the brain, by binding to its receptors, thereby promoting a calming effect.
FutureWise Market Research has published a report that provides an insightful analysis of Anticonvulsants Market trends that are affecting the overall market growth.
Request a Free Sample @ https://www.futurewiseresearch.com/contact.aspx?rpt=12458&type=requestsample
Anticonvulsants Market Segmentation:
By Drug Class
- Barbiturates
- Benzodiazepines
- Hydantoins
- Succinimides
- Others
By Application
- Epilepsy
- Migraine
- Fibromyalgia
- Neuropathic pain
- Anxiety
- Bipolar disorder
By Route of Administration
- Enteral
- Parenteral
- Topical
By Distribution Channel
- Retail Pharmacy
- Hospital Pharmacy
- Online Pharmacy
By Region
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Competitive Landscape in Anticonvulsants Market:
- Abbott Laboratories
- Teva Pharmaceutical Industries Ltd.
- Johnson & Johnson
- Novartis AG
- Pfizer Inc.
- Valeant Pharmaceuticals International, Inc.
- Sanofi S.A.
- UCB Group
- Shire Plc.
- GlaxoSmithKline Plc.
- Cephalon Inc.
- AstraZeneca Plc.
Buy now the latest version of this report: https://www.futurewiseresearch.com/checkout.aspx?ReportId=12458&license=multi
**Objectives of this Study: **
- To provide a comprehensive analysis of the Anticonvulsants Market By Drug Class, By Application, By Route of Administration, By Distribution Channel and By Region.
- To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
- To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
- To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Flexible Delivery Model:
- We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
- The customization services offered are free of charge with the purchase of any license of the report.
- You can directly share your requirements/changes to the current table of contents to: sales@futurewiseresearch.com
